Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2006; 12(6): 961-965
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.961
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.961
Table 1 Characteristics of patients
| n | Male/female | Age (yr) | ALT (U/L) | AST (U/L) | Alkaline phosphatase (U/L) | Bilirubin (µmol/L) | |
| CHC | 100 | 52/48 | 42.08 ± 3 | 108.7 ± 10.12 | 75.6 ± 8.76 | 141.7 ± 6.78 | 18.9 ± 2.42 |
| Control | 30 | 16/14 | 40.79 ± 2 | 21.3 ± 1.92 | 18.5 ± 1.73 | 136.4 ± 6.56 | 13.8 ± 1.76 |
- Citation: Janczewska-Kazek E, Marek B, Kajdaniuk D, Borgiel-Marek H. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-β1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(6): 961-965
- URL: https://www.wjgnet.com/1007-9327/full/v12/i6/961.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i6.961